These diverse mutations converge on specific pathways and processes, including KRAS, TGF-β, WNT, Notch signaling, chromatin remodeling and DNA repair pathways (Australian Pancreatic Cancer Genome Initiative et al., 2015; Raphael et al., 2017). This evidence concerns the gene KRAS and familial pancreatic carcinoma.